TiGenix is a European cell therapy company specializing in the use of allogeneic expanded adipose-derived stem cells for the treatment of autoimmune and inflammatory diseases
TiGenix is a European cell therapy company specializing in the use of allogeneic expanded adipose-derived stem cells for the treatment of autoimmune and inflammatory diseases. The company has a validated platform technology and has commercialized products, focusing on living cell therapies rather than conventional drugs.